Dr Reddy’s appoints Erez Israeli as COO
Dr Reddy’s Laboratories Ltd has appointed Erez Israeli, former President and CEO of Enzymotec, as new Chief Operating Officer (COO) and Global Head of Generics & PSAI. The present COO, Abhijit Mukherjee, has retired recently on March 31, 2018. Erez Israeli joined the Hyderabadbased company on April 2, 2018.
Israeli has held leadership positions in his career of 25 years. Prior to Enzymotec, he had completed 23 years with Teva Pharmaceuticals Ltd, where he held several positions of responsibility, including VicePresident, Marketing & Sales for North America, Vice-President, Asia Operations, President, Teva API, Group Executive Vice-President, Head of Global Quality, and President & CEO of Growth Markets.